 Connection
Jesse Schold to Tacrolimus
This is a "connection" page, showing publications Jesse Schold has written about Tacrolimus.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.955 |
|
|
|
-
Schold JD. The burden of proof in the design of early phase clinical trials. Am J Transplant. 2013 Jul; 13(7):1631-2.
Score: 0.402
-
Schold JD, Kaplan B. AZA/tacrolimus is associated with similar outcomes as MMF/tacrolimus among renal transplant recipients. Am J Transplant. 2009 Sep; 9(9):2067-74.
Score: 0.306
-
Elfadawy N, Flechner SM, Liu X, Schold J, Tian D, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB. The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation. Transpl Int. 2013 Aug; 26(8):822-32.
Score: 0.100
-
Meier-Kriesche HU, Schold JD, Srinivas TR, Howard RJ, Fujita S, Kaplan B. Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant. 2005 Sep; 5(9):2273-80.
Score: 0.058
-
Kaplan B, Schold JD, Meier-Kriesche HU. Long-term graft survival with neoral and tacrolimus: a paired kidney analysis. J Am Soc Nephrol. 2003 Nov; 14(11):2980-4.
Score: 0.051
-
Claes K, Meier-Kriesche HU, Schold JD, Vanrenterghem Y, Halloran PF, Ekberg H. Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study. Nephrol Dial Transplant. 2012 Feb; 27(2):850-7.
Score: 0.022
-
Srinivas TR, Kaplan B, Schold JD, Meier-Kriesche HU. The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation. Transplantation. 2005 Oct 15; 80(2 Suppl):S211-20.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|